These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6888271)

  • 21. Dependence of upper limit of metastability on supersaturation in nephrolithiasis.
    Asplin JR; Parks JH; Coe FL
    Kidney Int; 1997 Dec; 52(6):1602-8. PubMed ID: 9407506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of glucose intake on urine saturation with calcium oxalate, calcium phosphate, uric acid and sodium urate.
    Głuszek J
    Int Urol Nephrol; 1988; 20(6):657-64. PubMed ID: 3229936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of parathyroidectomy on crystallization of calcium salts in urine of patients with primary hyperparathyroidism.
    Pak CY
    Invest Urol; 1979 Sep; 17(2):146-8. PubMed ID: 468514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new urinary test for stone "activity".
    Hallson PC; Rose GA
    Br J Urol; 1978 Dec; 50(7):442-8. PubMed ID: 753493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation.
    Pylypchuk G; Ehrig U; Wilson DR
    Can Med Assoc J; 1979 Mar; 120(6):658-65. PubMed ID: 436047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of pH on the risk of calcium oxalate crystallization in urine.
    Berg C; Tiselius HG
    Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine composition and stone formation during treatment with acetazolamide.
    Ahlstrand C; Tiselius HG
    Scand J Urol Nephrol; 1987; 21(3):225-8. PubMed ID: 3433023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence justifying a high fluid intake in treatment of nephrolithiasis.
    Pak CY; Sakhaee K; Crowther C; Brinkley L
    Ann Intern Med; 1980 Jul; 93(1):36-9. PubMed ID: 7396311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ; Kinder JM; Asplin JR; Coe BJ; Coe FL
    J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New methods of assessing crystal growth and saturation of brushite in whole urine: effect of pH, calcium and citrate.
    Pak CY; Rodgers K; Poindexter JR; Sakhaee K
    J Urol; 2008 Oct; 180(4):1532-7. PubMed ID: 18710766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation.
    Tang R; Nancollas GH; Giocondi JL; Hoyer JR; Orme CA
    Kidney Int; 2006 Jul; 70(1):71-8. PubMed ID: 16641926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystallization conditions in urine of patients with idiopathic recurrent calcium nephrolithiasis and with hyperparathyroidism.
    Baumann JM; Lauber K; Lustenberger FX; Wacker M; Zingg EJ
    Urol Res; 1985; 13(4):169-74. PubMed ID: 4049602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case-control study of dietary intake of renal stone patients. II. Urine biochemistry and stone analysis.
    Griffith HM; O'Shea B; Maguire M; Koegh B; Kevany JP
    Urol Res; 1986; 14(2):75-82. PubMed ID: 3727218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correspondence between stone composition and urine supersaturation in nephrolithiasis.
    Parks JH; Coward M; Coe FL
    Kidney Int; 1997 Mar; 51(3):894-900. PubMed ID: 9067927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
    Bushinsky DA; Bashir MA; Riordon DR; Nakagawa Y; Coe FL; Grynpas MD
    Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epitaxial relationships in urolithiasis: the brushite-whewellite system.
    Meyer JL; Bergert JH; Smith LH
    Clin Sci Mol Med; 1977 Feb; 52(2):143-8. PubMed ID: 844247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.